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The open reading frame (ORF) and the regulated synthesis of the influenza C viral NS1 protein were analyzed in view of
viruses possessing different biological activities. We provide evidence for a 246-amino-acid NS1-ORF, encoded by five viral
strains and variants. Prokaryotic expression of the prototype NS1-ORF resulted in a product of 27 kDa, confirming the
predicted molecular weight. Using an antiserum raised against recombinant NS1 protein, nonstructural proteins of wild-type
virus were detected in infected cells for a limited course of time, whereas a persistent virus variant was characterized by a
long-term nonstructural gene expression. As examined by infection experiments, the intracellular distribution of nonstructural
protein was nuclear and cytoplasmic, whereas in NS1 gene-transfected cells, the cytoplasmic localization occurred in a
fine-grained structure, suggesting an analogy to influenza A viral NS1 protein. Concerning persistent infection, NS1 protein
species differing in sizes and posttranslational modifications were observed for a persistent virus variant, as particularly
illustrated by a high degree of NS1 phosphorylation. Virus reassortant analyses proved the importance of the NS-coding
genomic segment: the minimal viral properties required for the establishment of persistence were transferred with this
segment to a monoreassortant virus. Thus the influenza C viral NS1 protein is a 246-amino-acid nuclear-cytoplasmic
phosphoprotein that can be subject to specific variations being functionally linked to a persistent virus phenotype. © 1999
Academic Press
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The NS1 protein of influenza C virus is encoded by
NA segment 7, which is 935 nucleotides in length. An
pen reading frame (ORF) for NS1 had been proposed,
oding for a polypeptide of 286 amino acids (Buonagurio
t al., 1986; Nakada et al., 1985). In another report, how-
ver, an NS1-ORF of 246 amino acids in length was
escribed after determining the complete NS gene se-
uence of C/Yamagata/1/88 and a partial sequence of
/Ann Arbor/1/50 virus (Hongo et al., 1992). This contro-
ersial situation awaited further analysis. Functional as-
ects of the influenza C viral NS1 protein were less
ntensively studied than those of the corresponding pro-
ein of influenza A virus. Influenza A viral NS1 protein is
nown to be a nonstructural phosphorylated protein
Privalsky and Penhoet, 1981; Ward et al., 1994) that is
ocalized in the nucleus and nucleoli as well as at poly-
omes in the cytoplasm of infected cells. It is encoded by
n unspliced mRNA from the NS1-ORF of segment 8 and
s preferentially synthesized at early times in the virus
ycle (reviewed by Lamb, 1989). The RNA binding activity
1 To whom reprint requests should be addressed at Institut fu¨r
linische und Molekulare Virologie, Universita¨t Erlangen-Nu¨rnberg,
chloßgarten 4, 91054 Erlangen, Germany. Fax: (09131) 852-6493.a-mail: mdmarsch@viro.med.uni-erlangen.de.
042-6822/99 $30.00
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208f influenza A viral NS1 protein shows binding specificity
or different targets, such as for poly(A)1 sequences (Qiu
nd Krug, 1994), and leads to a regulated nuclear mRNA
xport (Alonso-Caplen et al., 1992). Moreover, NS1 pro-
ein is associated with spliceosomes and inhibits pre-
RNA splicing (Fortes et al., 1994; Lu et al., 1994). Addi-
ional activities were postulated, such as NS1 protein,
as shown to act as a positive regulator of translation
de la Luna et al., 1995; Enami et al., 1994; reviewed by
rtin, 1998).
In several studies on variant isolates of influenza A
irus, the involvement of nonstructural proteins in the
etermination of different phenotypes was investigated
Lucas et al., 1988; Ludwig et al., 1995; Perdue, 1992;
rabe et al., 1994; Ward et al., 1995), particularly raising
he question of NS-specific mechanisms leading to per-
istent infection. For influenza C virus, a persistence
odel was established in cultured canine kidney cells
Camilleri and Maassab, 1988). Viral persistence was
ransfered by secondary infection to a human lung cell
ine (Marschall et al., 1996a), and persistent viral RNAs
ere detected in lung tissues of experimentally infected
hickens (Helten et al., 1996). Productive and nonproduc-
ive phases of persistence were observed (Marschall et
l., 1993; Zach et al., in press), both associated with an
xtremely low degree of virus-induced cytopathology
nd apoptosis compared with lytic types of infection
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209INFLUENZA C VIRAL NS1 PROTEINHechtfischer et al., 1997; unpublished observations).
he viral particles released from persistently infected
ells were characterized by their typical properties due
o a modified HEF surface glycoprotein, such as by
ltered receptor binding and acetylesterase activities
Marschall et al., 1994). Distinct mutations in different
enomic segments of the persistent variant were identi-
ied (e.g., for the viral polymerase gene PB2) (Lapatschek
t al., 1995).
In this study, we demonstrate that the NS1 protein of
ive influenza C viruses is encoded by an ORF of 246
mino acids that underlies variant-specific sequence al-
erations. Examination of NS1 protein synthesis revealed
ew aspects of protein kinetics, intracellular distribution,
nd posttranslational modification. With regard to persis-
ent viruses, the importance of a mutant form of NS1
rotein was illustrated by different approaches.
RESULTS
Nucleotide sequence analysis was performed to de-
ermine the ORF encoding the NS1 protein of influenza C
iruses. For this, RT-PCR products of the genomic RNA
egment 7 of five virus isolates were generated and used
or cloning or direct sequence determination (Table 1).
omplete sequences of the two virus variants of strain
/Ann Arbor/1/50 (C/AA-wt and C/AA-pi) and partial se-
uences of the strains C/JHB, C/TAY, and C/ENG were
nalyzed. The sequence around the NS1 start codon was
etermined separately by the use of RT-PCR products
erived from an additional pair of PCR primers (see
aterials and Methods). Data were compared with the
utative NS1-ORFs described in previous studies. The
S1-ORF resulting from our analysis is composed of 738
oding nucleotides and is defined by an ATG start codon
TABLE 1
Comparison of Partial Nucleotide Sequences Which Are
Responsible for the Determination of Two Different NS1-ORFs
Influenza C virus Nucleotide sequences 690–710a
C/AA-wtb CCC TAT TGG GGA AAT GAA AAA
C/AA-pib CCC TAT TGG GGA AAT GAA ACA
C/JHBc CCC TAT TGG GGA AAT GAA AAA
C/TAYc CCC TAT TGG GGA AAT GAA ACA
C/ENGc CCC TAG TGG GGN AAT GAA AAA
C/YAMd CCC TAT TGG GGA AAT GAA ACA
C/AAe CCC TAT TGG GAA ATG AAA CAC
a The presence of a distinct G residue at position 700 is indicated by
nderlining.
b Sequences determined from clones pGEX-NSwt and pGEX-NSpi.
c Sequences directly determined from RT-PCR products.
d Sequence published by Hongo et al. (1992) and partly reinvesti-
ated here by the use of clone pCNS5-8.
e Sequence published by Buonagurio et al. (1986).t position 27 and a TAA stop codon at position 765. All eS1-ORF sequences analyzed (including a reinvestiga-
ion of NS1 of strain C/YAM) contained an additional G
esidue at nucleotide position 700, which was missing in
equences published previously. The integrity of this
ucleotide position was confirmed by several indepen-
ent sequencing templates and by PCRs involving enzy-
atic proof reading activity. Thus the NS1-ORF described
ere differs from that reported in earlier studies (Buon-
gurio et al., 1986; Nakada et al., 1985) but is identical to
hat described recently (Hongo et al., 1992).
Given this information, we deduced the complete NS1
mino acid sequences of viruses C/AA-wt and C/AA-pi
Table 2). A polypeptide of 246 amino acids in length was
etermined including nine coding mutations differing be-
ween the two viruses. Five of these changes (amino acid
ositions 39, 84, 96, 189, and 232) were characteristic for
he variant C/AA-pi and did not occur in published se-
uences of other viral strains. The C-terminal part of
/AA-wt and C/AA-pi viral NS1 protein varieties (starting
t amino acid 225) was distinct from the NS1-ORF of viral
equence C/AA, as explained by the additional G residue
t position 700.
Expression of the NS1-ORFs of variants C/AA-wt and
/AA-pi (Fig. 1A) was performed in Escherichia coli and
ST-NS1 fusion proteins were detected on Western blots
Fig. 1B). A small variation in protein sizes of the respec-
ive clones was visualized (in particular, by extended
uns of electrophoretic separation), indicating that
lightly varied gel mobilities might be due to the amino
cid changes presented in Table 2. Cleavage of wild-type
ST-NS1 protein by thrombin digestion resulted in a NS1
roduct of ;27 kDa (data not shown). This is consistent
ith the theoretical molecular mass of 27.8 kDa derived
rom the NS1-ORF described here (246 amino acids) and
iffers from that formerly calculated as 32.4 kDa (286
mino acids). GST-NS1 protein was used to raise rabbit
ntiserum Z-NS1 for the characterization of native viral
S1 protein in infected cells.
An infection kinetic of the virus variants C/AA-wt and
/AA-pi in MDCK cells was monitored at the time points
h and 1, 2, 3, 5, and 7 days postinfection (p.i.) by indirect
mmunofluorescence double-stainings of NS1/NP and
S1/HEF proteins (data not shown). Wild-type virus
/AA-wt was characterized by an early onset (8 h) of
onstructural protein synthesis, showing a maximum be-
ween days 1–3, and a steady reduction at later time
oints that ended in a complete loss of signals. Struc-
ural proteins NP and HEF produced by C/AA-wt virus
aralleled this kinetic but showed a slight delay in their
nset as well as in termination of synthesis. The persis-
ent virus variant C/AA-pi, however, started at 1 day p.i. to
roduce continuously detectable amounts of viral non-
tructural proteins and, in a delayed fashion, of structural
roteins as well. No reduction in protein synthesis was
oted within the period of 7 days investigated. In kinetic
xperiments described elsewhere, NS1 protein synthe-
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211INFLUENZA C VIRAL NS1 PROTEINis of the persistent virus C/AA-pi was monitored along a
eriod of 55 days (Marschall et al., 1998). Thus NS-
pecific expression of the persistent virus is not subject
o a strict down-regulation on the protein or on the RNA
evel (Zach et al., in press), as described for the late
FIG. 1. Expression plasmids and prokaryotic production of GST-NS1.
A) For prokaryotic expression (top), NS1-ORF was placed downstream
f the tac-promoter (Ptac) and the glutathione-S-transferase coding
equence (GST) to generate GST-NS1 fusion protein. Thn indicates
hrombin cleavage site. For transient eukaryotic expression (middle),
S1 production was controlled by the SV40 promoter/enhancer (SV40
/e) and the terminal polyadenylation consensus sequence [Poly(A)].
or stable eukaryotic expression (bottom), a neo-selectable construct
as used, allowing that NS1 production was constitutively driven by
he CMV promoter/enhancer (CMV p/e) linked to the splicing signals of
MV intron A. (B) Lysates of three pGEX-NSwt clones (lanes 2, 4, and
), three pGEX-NSpi clones (lanes 3, 5, and 7), and vector clone
GEX-2T (lane 1) were separated by extended SDS–PAGE (to the point
here GST was released into the flowthrough) and subjected to West-
rn blotting. The specific staining of recombinant proteins (GST-NS1)
as achieved by the use of anti-GST antibodies (Pharmacia). Note a
light variation in molecular weights between pGEX-NSwt and pGEX-
Spi clones (arrowhead). Asterisk indicates cross-reaction with a bac-
erial protein (Yu-Sherman and Goldberg, 1992); marker bands indi-
ated on the left (High Molecular Weight Standard Mixture, Sigma),
16/97.4/66/45 kDa.hase of wild-type viral replication. With regard to the aong-term maintenance of viral persistence, however,
rotein synthesis may occur in changes between pro-
uctive and nonproductive phases (Marschall et al.,
993).
Concerning the subcellular localization of viral NS1
rotein, cytoplasmic and nuclear staining signals (i.e.,
ells stained in either or both of the two compartments)
ere obtained. MDCK cells infected with C/AA-pi virus
ere double-stained for nonstructural and nucleoprotein
NP) synthesis 3 days p.i. (Figs. 2, A–C). Both viral pro-
eins did not underly a strict subcellular compartmenta-
ion in infected cells but were frequently distributed over
he whole cell bodies. In cells transfected with either
S1 or NP genes separately, however, distinct localiza-
ions of the synthesized proteins became detectable.
nterestingly, the predominant cytoplasmic distribution of
S1 protein occurred in a fine-grained structure as par-
icularly illustrated by confocal immunofluorescence (Fig.
E). This microscopic pattern clearly differed from that of
ecombinantly expressed NP protein, which showed a
assive nuclear accumulation (Fig. 2F). Thus NS1 and
P proteins of the persistent virus variant possess spe-
ific localization properties that are clearly detectable in
ransfected but less defined in infected cells.
The virus variant-specific synthesis of NS1 protein was
urther demonstrated in infected MDCK cells by Western
lot analysis (Fig. 3A). C/AA-wt virus was shown to pro-
uce one major NS1 product at 20 h p.i. (lane 2), which
as reduced to lower amounts at 50 h p.i. (lane 3) and
isappeared at later time points as determined in differ-
nt experiments. In contrast to this, C/AA-pi virus in-
uced the synthesis of two forms of NS1 proteins, both
etectable at variable time points of productive persis-
ent infection (lane 4), whereas none of these NS1 prod-
cts were present during nonproductive intervals (lane
). As a control, viral matrix protein (M) was detected in
arallel using the same cell samples. The differences in
irus variant-specific gene expression were also re-
lected by the quantities of M protein synthesis, whereas
o variation in M protein sizes was determined (Fig. 3B).
erforming recombinant expression of NS1 in trans-
ected MDCK-NSpi cells, the variant nature of persistent-
ype NS1 protein was confirmed. In these cells, the two
orms of NS1 proteins were synthesized (Fig. 3C), which
ere indistinguishable from those seen in persistently
nfected cells. This indicates that the modified NS1 ex-
ression of the virus variant C/AA-pi is independent from
he action of further viral proteins.
Detailed analysis of NS1 protein varieties was per-
ormed by RIPA using infected cell lysates. C/AA-wt vi-
us-derived NS1 protein was determined with a molecu-
ar weight of 27 kDa, identical to that produced by other
iral strains (Fig. 4a). An additional faint band of 28 kDa
as detectable at times (data not shown). The C/AA-pi
ariant, however, produced NS1-specific proteins of 26.5
nd 27.5 kDa, which were not found in samples of other
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212 MARSCHALL ET AL.iruses tested. This variation was considered to corre-
ate with the distinct amino acid changes in the NS1
equence, in particular to those concerning putative
hosphorylation sites (Table 2). To address this item, we
pecified the RIPA analysis for phosphoproteins. As
hown in Fig. 4b, we identified a NS1-specific phosphor-
lated polypeptide of 27.5 kDa for the C/AA-pi variant,
hich is identical with the 27.5-kDa protein detected in
ig. 4a, as indicated by the control lane (S). On overex-
FIG. 2. Intracellular distribution of the viral proteins NS1 and NP du
ab-Tek slides, infected with C/AA-pi virus or mock-infected, and incuba
ouble-staining for the detection of viral NS1 (A, antiserum Z-NS1) and
uclei were counterstained by the use of DAPI reagent (C). Mock-infe
ere transfected with pSV-NSpi and cultured on Lab-Tek slides. Three
nalysis using antiserum Z-NS1. In confocal laserscanning microscopy
op (upper left) to the medial cell body (lower right). Note the structure
ith pI18-NPpi, cultured for 1 day, and spotted onto glass slides for imm
sed to visualize recombinant NP expression in a marked nuclear accosure, very small amounts of a 28-kDa NS1 phospho- protein were also detectable for other viral strains (data
ot shown). These findings indicate that NS1 protein of
nfluenza C virus is posttranslationally modified by phos-
horylation and that the variant C/AA-pi produces a 27.5-
Da species of NS1 phosphoprotein in a constitutive
anner during productive persistent phases.
The significance of variant NS1 expression for the
etermination of viral persistence was investigated by
eassortant virus analyses. After a long-term selection
ection or recombinant expression. (A–D) MDCK cells were grown on
3 days. After fixation, the slides were assayed by immunofluorescence
teins (B, MAb-NP F17) in identical fields of infected cells (arrowheads);
lls served as a negative control (D, antiserum Z-NS1). (E) COS7 cells
after transfection, NS1 protein was detected by immunofluorescence
ic signals were monitored in serial layers of 0.5-mm distance from the
lasmic staining pattern (arrowhead). (F) MDCK cells were transfected
orescence analysis. Anti-C/JHB virus hyperimmune serum (H1/66) was
ion (arrowhead). Microscopic magnification, 4003.ring inf
ted for
NP pro
cted ce
days
, specif
d cytop
unoflurocedure in infected MDCK cells, we succeeded in the
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213INFLUENZA C VIRAL NS1 PROTEINsolation of a monoreassortant virus, C/R1, possessing
haracteristics of a persistent variant. The genomic
tructure of C/R1 virus consisted of a genetic back-
round derived from the parental virus C/JHB, in a novel
ombination with the NS-encoding RNA segment origi-
ating from the persistent variant C/AA-pi (Table 3). In
nfection experiments, C/R1 virus behaved very similar to
he variant C/AA-pi, concerning the long-term intracellu-
ar stabilization of viral RNAs, whereas RNA signals for
/JHB virus were not detectable .9 days p.i. (Fig. 5A). As
epicted by Western blot analysis (Fig. 5B), the NS1-
pecific expression pattern was identical between the
iruses C/R1 and C/AA-pi: two protein varieties of 26.5
nd 27.5 kDa were stably produced during the time range
nalyzed. In contrast, C/JHB virus infection gave rise to
he wild-type form of a 27-kDa NS1 protein, which was
nly transiently detectable at 1 day p.i. Determinations of
ndividual biological characteristics of the reassortant
irus C/R1 clearly illustrated its relatedness to C/AA-pi
irus in establishing persistent infections in MDCK cells,
hereas certain parameters also indicated a slightly
ifferent, intermediate phenotype with respect to both
arental viruses (Table 4). As indicated by the predomi-
ance of continued nonproductive phases (i.e., the ex-
lusive presence of viral RNA in the absence of virus
roduction), it is suggestive that the C/R1 virus is
quipped by the minimal genetic information required for
ersistent infection. Thus the influenza C viral NS-coding
egment contributes as a major determinant to the es-
FIG. 3. Viral NS1 (A) and M proteins (B) produced in infected cells.
DCK cells were freshly infected with C/AA-wt virus and analyzed 20
nd 50 h p.i. MDCK-pi cells were harvested at times with and without
irus production (i.e., positive or negative hemagglutination signals
rom the culture medium). Lysates were separated by 17.5% SDS–
AGE, Western-blotted and exposed to the antiserum Z-NS1 or, as a
ontrol, to monoclonal antibodies against the matrix protein (MAb-M
2), respectively. Staining was performed by standard procedures us-
ng AP-conjugated antibodies. 1 indicates uninfected MDCK cells
MOCK); 2, MDCK cells infected with C/AA-wt virus for 20 h; 3, MDCK
ells infected with C/AA-wt virus for 50 h; 4, MDCK-pi cells in a
roductive phase; and 5, MDCK-pi cells in a nonproductive phase. (C)
ecombinant NS1 expression in MDCK-NSpi cells. MDCK cells were
ransfected with plasmid pI18neo-NSpi, selected for stably growing cell
lones and analyzed by Western blotting as described in Fig. 3A.ablishment of in vitro persistence. sDISCUSSION
An influenza C viral NS1-ORF was identified that dif-
ers in its C-terminal part from an NS1-ORF reported
arlier (Buonagurio et al., 1986; Nakada et al., 1985) and
s identical to that described previously for strain
/Yamagata/1/88 (Hongo et al., 1992). This finding has
TABLE 3
Genomic Structure of Reassortant Virus C/R1
Genomic segment Restriction typinga Sequencingb
PB2 C/JHB C/JHB
PB1 C/JHB C/JHB
P3 N.D. C/JHB 5 C/AA-pi
HEF C/JHB C/JHB
NP C/JHB C/JHB
M C/JHB C/JHB
NS C/AA-pi C/AA-pi
a RT-PCR products of genomic segments were analyzed by a virus
ariant-specific restriction typing (Marschall et al., 1998).
b Partial nucleotide sequences were determined for genomic sec-
ions of PB2 nt 1–309, PB1 nt 948–1543, P3 nt 784–1447, HEF nt
013–1731, NP nt 1308–1756, M nt 383–720, and NS nt 126–843; the
rigin of segments was deduced from variant-specific positions (Mar-
FIG. 4. NS1-specific proteins and NS1 phosphorylation identified for
ifferent influenza C viruses. (a) Immunoprecipitation of NS1-specific
roteins was performed using lysates of cells infected with different
nfluenza C viruses (C/JHB I and C/JHB II represent stock viruses from
ifferent sources). MDCK cells were infected for 36 h and labeled in
ivo by an incubation in the presence of 35S-methionine plus 35S-
ysteine (50 mCi ICN Tran35S-Label/ml medium) for 24 h. Cell lysates
ere subjected to immunoprecipitation using antiserum Z-NS1, sepa-
ated by SDS–PAGE and exposed to radiography films. (b) The dem-
nstration of a posttranslational modification of NS1 polypeptides was
chieved by immunoprecipitation of phosphoproteins. MDCK cells
ere infected with different influenza C viruses for 36 h and labelled in
ivo by an incubation in the presence of inorganic 32P-phosphate (330
Ci/ml medium, ICN) for 12 h. The immunoprecipitation of NS1-specific
hosphoproteins was performed as described in Fig. 5a. Control reac-
ions were carried out by dephosphorylation of the precipitate with
lkaline phosphatase (AP) and by a precipitation control using a lysate
abelled with 35S-methionine/cysteine (S). Mock indicates uninfected
ells.chall et al., 1996; P3 sequences were identical).
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214 MARSCHALL ET AL.mplications on the primary structure of the NS1 protein
246 instead of 286 amino acids) and also of the NS2
rotein (182 instead of 121 amino acids) because NS2 is
nown to be generated via a spliced mRNA derived from
he same genomic segment (Nakada et al., 1986). Protein
ata derived from recombinant NS1 expression and from
nfection experiments confirmed our sequence determi-
ation.
As illustrated by kinetic studies, viral NS1 protein is
ynthesized in the early period of infection. The subcel-
ular localization of NS1 protein is nuclear and cytoplas-
ic, whereby the cytoplasmic localization may occur in
ypical fine-grained structures. This cytoplasmic staining
attern is reminiscent to the immune electron micro-
copic picture showing similar structures of influenza A
iral NS1 protein recombinantly expressed in yeast cells
nd observations made in infected cells. Such electron-
ense cytoplasmic inclusions were likely to correspond
FIG. 5. Monoreassortant virus C/R1: long-term persistence of viral
NA and variant-specific pattern of NS1 protein synthesis. (A) Persis-
ence of the viral NS coding segment was analyzed by RT-PCR in
nfected MDCK cells. An amplification product of 899 bp was detected
or C/AA-pi or C/R1 viruses at 9, 27, and 42 days p.i. (dpi) for C/JHB virus
t 9 days p.i. VI indicates DNA marker (2176, 1766, 1230, 1033, 653, 517,
53, 394, and 298 bp; Boehringer-Mannheim). (B) Infected MDCK cells
ere harvested 1 and 3 days p.i. Lysates were separated by 17.5%
DS–PAGE and subjected to Western blotting. The variant-specific
attern of viral NS1 protein was detected by the antiserum Z-NS1 and
ndirect alkaline phosphatase staining. Marker bands indicated on the
eft (Dalton Mark VII-L, Sigma; 66, 45, 36, 29, and 24 kDa); MOCK
ndicates uninfected cells.o a direct self-interaction of NS1 (Ward et al., 1994). In lact, NS1 multimer formation was demonstrated using
he yeast two-hybrid system (Nemeroff et al., 1995).
In infection experiments, those influenza C viruses
ollowing a short-lived wild-type course of replication
ere characterized by the transiently limited synthesis of
ne major NS1 protein species, whereas a persistent
ariant continuously produced two protein species in
omparable quantities along productive periods of per-
istence. This variant form of expression was attributed
o the effects of NS1 gene mutation and posttranslational
rotein modifications: nine coding mutations were iden-
ified for the NS1 protein of the persistent variant with
espect to wild-type virus. The occurrence of a mutant
ene resulting in the production of a variant form of the
S1 protein was also reported for a persistent influenza
virus. Hereby, the NS1 variation was suggested to be
nvolved in the development of the persistent virus phe-
otype (Lucas et al., 1988). NS1 phosphorylation on thre-
nine residues was demonstrated for influenza
/NWS/33 virus (Privalsky and Penhoet, 1981). The oc-
urance of two NS1 proteins, differing in molecular
eights and quantities from their wild-type counterparts,
as found for influenza C/AA-pi virus and was explained
y a distinct way of protein phosphorylation. This finding
oints out the significance of four potential threonine
hosphorylation sites varying between the NS1 proteins
f C/AA-pi and C/AA-wt viruses. In case of the persistent
ariant, the loss of two threonine residues on the one
ide and the gain of two different threonine residues on
he other side might alter the effectiveness and stability
f NS1 phosphorylation.
The production of two NS1 protein modifications was
ndependent from other viral proteins as indicated by the
ecombinant expression in MDCK-NSpi cells. Hence, the
dentified persistent-type NS1 protein modifications are
TABLE 4
Biological Characteristics of Parental and Reassortant Viruses
Parameter
Viruses
C/JHB C/AA-pi C/R1
llantoic growth rates in
embryonated eggsa
High Low High
ersistent infections in
MDCK cellsb
No Yes Yes
iral replication phases
during persistencec
Mainly
productive
Mainly
nonproductive
S1 protein variationb No Yes Yes
a Viral progeny titers were determined by hemagglutination (HA)
ests. High, #512 (C/JHB), #128 HAU/ml (C/R1); low, #4 HAU/ml (C/
A-pi, first egg passage). Titrations were performed in triplicate at
east.
b Data shown in Fig. 5.
c Viral persistence was categorized by the predominance of positive
productive) or negative (nonproductive) HA test results obtained from
ong-term infected MDCK cells.
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215INFLUENZA C VIRAL NS1 PROTEINolely generated by cellular or NS1-derived processes.
he two NS1 proteins might represent an unphosphory-
ated precursor and a phosphorylated target protein pos-
essing different activities and being coexpressed dur-
ng productive phases of viral persistence. Interestingly,
ero cells infected with the variant C/AA-pi do not sup-
ort a long-term persistence and do not produce equal
uantities of two coexisting NS1 protein species. In con-
rast, they show almost exclusively the production of the
aster migrating, unphosphorylated 26.5-kDa NS1 protein
unpublished observation).
Furthermore, in studies on persistent virus RNA syn-
hesis and transport, an aberrant manner of NS-specific
ranscription was described for the persistent variant
/AA-pi. The synthesis of segment 7 positive-strand
NA, continuing along the productive course of persis-
ent infection, did not follow a specific down-regulation
s it occurred in the late phase of wild-type virus infec-
ion (Zach et al., in press). The lack of this down-
egulatory event might explain in part the specialized
inetics of NS1 protein synthesis and consequences
hereof.
The importance of NS1 protein for persistent infection
as further illustrated by reassortment studies. In these
xperiments, the monoreassortant virus C/R1 showed a
henotype of infection that was similar to parental virus
/AA-pi, particularly concerning the long-term persis-
ence of intracellular viral RNA. Although the possibility
f different impacts of NS1 and NS2 proteins could not
e distinguished by this approach, our results clearly
ndicate that the NS-coding genomic segment is a major
eterminant of viral persistence. Of note, not all the viral
haracteristics linked to a persistent phenotype were
ransferred with the mutant NS-coding segment. This
ituation suggests that further mutant viral gene prod-
cts, minor determinants of persistence like PB2 (Lapat-
chek et al., 1995), HEF (Marschall et al., 1994), and M
nd NP (Hechtfischer et al., submitted for publication),
ight act in a cumulative manner and might influence
he stability and frequency of persistent infections. Anal-
gous studies on the in vitro persistence of poliovirus
utants are in accordance with this scenario because
hey suggest a comparable hierarchy of viral determi-
ants: distinct point mutations in viral capsid genes were
dentified as the minimal genetic markers of persistence,
ccompanied by mutations possessing importance for
he frequency at which this viral phenotype was estab-
ished (Duncan et al., 1998; Pelletier et al., 1998). In case
f persistent Sindbis virus variants, a single coding mu-
ation in the nonstructural gene nsP2 was described as
he essential determinant for noncytopathic infection and
iral persistence in vitro. Mutations identified in other
enes were considered to play an additional role by
ecreasing the level of persistent viral RNA synthesis
Dryga et al., 1997).
Concludingly, these results provide new insights in the deneral structure, the regulated synthesis and the mod-
fication of influenza C viral NS1 protein. Functional prop-
rties of NS1 need to be described in detail by future
nvestigations. As an important point of this work, the
dentified variations in the mode of nonstructural gene
xpression are suggestive to play an essential role in the
etermination of persistent infection.
MATERIALS AND METHODS
ells and viruses
MDCK, MDCK-pi, and MDCK-NSpi cells were culti-
ated in Dulbecco’s modified Eagle’s medium containing
0% (v/v) of fetal calf serum by refreshing the culture
edium twice a week. The persistently infected MDCK-pi
ine was grown at virus-permissive (33°C) or nonpermis-
ive temperatures (37°C) to induce productive or non-
roductive phases (Marschall et al., 1993, 1997). Stocks
f wild-type influenza C/AA-wt and C/AA-pi, as well as
he control viruses C/Johannesburg/1/66 (C/JHB), C/En-
land/84 (C/ENG), and C/Taylor/1233/47 (C/TAY), were
rown in MDCK cell cultures or in embryonated chicken
ggs for 3–5 days at 33°C. Virus titers, in allantoic fluids
r in cell culture supernatants, were determined by the
emagglutination microtitration method using 1%
hicken erythrocytes in PBS. Infection of MDCK cells
as performed in 12-well plates or in 12-cm2 culture
essels. Monolayers were rinsed twice with PBS and
verlaid with 500–1000 ml of virus inoculum diluted 1:2 in
BS. After an incubation for 1 h at 33°C under occasional
haking, the inoculum was removed by rinsing twice with
BS, and cells were cultivated in medium containing 2%
v/v) of fetal calf serum at 33°C.
eneration of reassortant viruses
The parental viruses C/JHB and C/AA-pi were coinocu-
ated and grown in the allantoic cavity of embryonated
en’s eggs. Progeny virus was harvested and passaged
o MDCK cells by infection and long-term cultivation of
he cultures. The reoccurrance of viral HA titers (after the
ommon initial peak of virus replication and a character-
stic HA-negative nonproductive phase) indicated the
stablishment of viral persistence. Virus was reisolated
nd subjected to several rounds of purification, that is, to
iral growth on limited dilution inoculation in embryo-
ated eggs or in MDCK cells (24-well plate assay; Mar-
chall et al., 1994) and to plaque purification in primary
hicken kidney cells (Petri et al., 1979). Putative reassor-
ant viruses were screened by restriction typing of RT-
CR products before viral stocks were prepared by
rowth in embryonated eggs and stored at 270°C.
T-PCR and sequence analysis
RT-PCR was performed by standard procedures as
escribed before (Marschall et al., 1995). In brief, virion
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216 MARSCHALL ET AL.NA was isolated and reverse transcribed by the use of
he universal primer Uni1 positioned at the conserved
9-ends of all vRNA segments (59-AGCAAAAGCAGG-39).
DNA was subjected to a 30-cycle PCR with temperature
evels of 95°C for denaturation (1 min), 50°C for anneal-
ng (1 min), and 72°C for polymerization (3 min). Viral
egments 7 (NS) and 5 (NP) were amplified by Taq or
wo DNA polymerases or by an enzyme mix composed
f both polymerases (Expand High Fidelity PCR System,
oehringer-Mannheim) using the following primer pairs
cloning linker sequences are given in brackets): C/7-
7/1 59-[TTGAGCTCTAG]ATGTCCGACAAAACAGTCAAA-
CAAC-39 or C/7-27b/1 59-[TTGAATTC]ATGTCCGACAA-
ACAGTCAAATCAAC-39 or C/7-27c/1 59-[TTGGATCC]AT-
TCCGACAAAACAGTC-39 and C/7-888/259-[TTGTCGAC-
CGGGTACCTTTATTTAT]TTATATAAGTGAATTACACA-
AG-39 (RT-PCR products used in Fig. 5A, as inserts for
SV-NSwt, pSV-NSpi, pGEX-NSwt, and pGEX-NSpi or as
irect sequencing templates); C/7-5/1 59-GAAGCA-
GGGTACTTTTCC-39 and C/7-636/2 59-CGGTAGCCATA-
CGAATCCGC-39 (additional RT-PCR products spanning
he 59-NS1 gene section) C/5-1/1 59-AGCAGAAGCAG-
AAGCTTTGGATCC]GAGATTTGGTTTTCAAAA-39 and
/5-1756/2 59-CAACAGTTGATCATAAAATA[GTCGACC-
GGG]TGTGATGAATTTAATCTGAC-39 (RT-PCR product
s insert for pI18-NPpi).
loning and transfer of expression plasmids
RT-PCR products containing the complete NS1-ORF
ere inserted into plasmid vectors pGEX-2T (Pharma-
ia), pSV1/2 (Marschall et al., 1991), and pI18neo (see
elow) as indicated in Fig. 1A. Appropriate restriction
ites of the inserts were generated either directly via
rimer linker sequences or indirectly via subcloning in
dditional transfer vectors. pI18neo was created by in-
ertion of the PCR-derived neomycin resistance gene
pBK-RSV nucleotides 2689-35; Stratagene) into the
indIII site of eukaryotic expression vector pI18, which is
riven by the human cytomegalovirus (CMV) immediate
arly promoter-enhancer linked to the CMV intron A. The
S1-coding BamHI–SmaI fragment of pGEX-NSpi was
nserted into pI18neo to generate the selectable expres-
ion plasmid pI18neo-NSpi. For constructing the control
lasmid pI18-NPpi, an RT-PCR product stretching the
P-ORF of influenza C/AA-pi virus was generated and
nserted into pI18 using restriction sites BamHI–SmaI.
igation was performed using the Rapid DNA Ligation Kit
Boehringer-Mannheim). Transformation of E. coli and
creening for positive clones was carried out by stan-
ard procedures (Sambrook et al., 1989). GST-NS1 pro-
eins were produced in E. coli and purified by the use of
ediPack GST Purification Module according to the pro-
ocol of the manufacturer (Pharmacia). The specific
leavage of GST from NS1 polypeptide fragments was
erformed by the incubation of thrombin (10 U/mg pro- mein) for $2 h at room temperature. Purified GST-NS1
rotein was used for subcutaneous immunizations of a
abbit to raise antiserum Z-NS1. This antiserum recog-
ized recombinant and virus-produced NS1 proteins and
ossibly also the N-terminal part shared by NS1 and NS2
roteins (62 amino acids). However, NS2-specific
olypeptides of the expected molecular weights were
ot detected in the different Western blot and RIPA ex-
eriments performed. Transfection of plasmids into eu-
aryotic cells was carried out by the electroporation
ethod using a Gene Pulser (BioRad). Selection of stably
xpressing clones was achieved by the incubation of 1
g/ml of geneticin (ICN). On transfection and selection
sing plasmid pI18neo-NSpi, MDCK-NSpi cell clones
ere obtained, which synthesized NS1 protein of the
xpected size, whereas NS2 coexpression (from a
pliced NS-specific RNA) was not observed.
ndirect immunofluorescence test and confocal
icroscopy
Cells were either grown on Lab-Tek carriers (Nunc) or
arvested from culture vessels, spotted onto glass
lides, and fixed by a 15-min treatment with 3% of form-
ldehyde in PBS followed by permeabilization for 15 min
n 0.1% of Triton X-100 in PBS at room temperature.
locking was achieved by preincubation of the slides
ith nonspecific horse serum for 30 min at 37°C. The
rimary antibody (GST-NS1-specific antiserum Z-NS1,
/JHB virus-specific antiserum H1/66, MAb-NP F17, or
Ab-HEF FCDD4•1/DA2•6•4) was incubated for 90 min
nd the secondary antibody (fluorescein-isothiocyanate-
r rhodamine-coupled anti-rabbit or anti-mouse antibod-
es, respectively) was incubated for 45 min at 37°C
efore analysis by fluorescence microscopy. Double-
tainings were performed as described elsewhere
Hechtfischer et al., submitted for publication; Marschall
t al., 1998). Nuclear counterstaining was carried out
sing Vectashield mounting medium with DAPI (Vector
aboratories, Burlingame, CA).
For confocal laser-scanning microscopy, Gelvatol cov-
rslip mounting medium in glycerol solution was used in
ombination with DABCO antibleaching agent (both
igma) to achieve rapid hardening of the labeled mate-
ial and to prevent the fading of signals during micro-
copic analysis (Rodriguez and Deinhardt, 1960). Micros-
opy was performed with a LSM Rfl 1 microscope (Zeiss)
y scanning serial layers of 0.5-mm distance at a mag-
ification of 1603. Data were processed using the AVS-
ystem computer program.
estern blot
Protein samples were denaturated under reducing
onditions in boiling mix buffer (3% saccharose, 2% SDS,
0 mM Tris, pH 7.5, 5% b-mercaptoethanol, 0.03% bro-
ophenol blue) and heated at 95°C for 10 min. Electro-
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217INFLUENZA C VIRAL NS1 PROTEINhoresis was performed by a 12.5–17.5% standard SDS–
AGE (Sambrook et al., 1989) in electrophoresis buffer
25 mM Tris, 192 mM glycine, 0.1% SDS). The transfer to
itrocellulose membranes was achieved in blotting
uffer (192 mM glycine, 25 mM Tris, 20% methanol) using
semidry Trans-Blot apparatus (BioRad) at room tem-
erature. Blots were blocked in a 5% milk powder solu-
ion and incubated with specific antibodies (dilutions,
:100 for antisera and 1:2000 for monoclonal antibodies)
or 4–15 h at room temperature. After washing, alkaline
hosphatase (AP)-conjugated antibodies were incubated
or 2 h at room temperature and subjected to color
evelopment using NBT/BCIP (Boehringer-Mannheim)
s AP substrates.
adioimmunoprecipitation assay (RIPA)
Viral proteins were labeled in vivo by the incubation of
5S-methionine/cysteine or 32P-inorganic phosphate in
he supernatants of infected cell cultures. Cells were
rypsinized and pelleted before protein extracts were
enerated by sonication in RIPA buffer (0.5% Nonidet
-40, 20 mM Tris, pH 9.0, 300 mM NaCl, 1 mM CaCl2, 0.5
M MgCl2, 2 mM EDTA, 2 mM PMSF, 10% glycerin).
hen, 100 ml of each cell extract were used for precipi-
ation with 100 ml of a preadsorbed antiserum (Z-NS1
ilution 1:20) for 4 h at room temperature. Specific pre-
ipitates were complexed with 100 ml of a solution of 3
g of Protein A–Sepharose beads (Pharmacia) in RIPA
uffer for 1 h at room temperature, washed repeatedly,
nd separated by SDS–PAGE. Gels were dried and ex-
osed to Hyperfilm-bMax autoradiography films (Amer-
ham) for 6–7 days.
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